These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1292694)

  • 1. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
    Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro].
    Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV
    Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain dependence of muramyl dipeptide-induced LAF(IL 1) release by murine-adherent peritoneal cells.
    Abehsira-Amar O; Damais C; Parant M; Chedid L
    J Immunol; 1985 Jan; 134(1):365-8. PubMed ID: 3871106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive immunomodulating properties and interactivity with model membranes and cells of two homologous muramyl dipeptide derivatives differing by their lipophilicity.
    Kalyuzhin OV; Zemlyakov AE; Fuchs BB
    Int J Immunopharmacol; 1996 Nov; 18(11):651-9. PubMed ID: 9089008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
    Todate A; Suda T; Kuwata H; Chida K; Nakamura H
    J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muramyl dipeptide induces production of hemopoietic growth factors in vivo by a mechanism independent of tumor necrosis factor.
    Broudy VC; Kaushansky K; Shoemaker SG; Aggarwal BB; Adamson JW
    J Immunol; 1990 May; 144(10):3789-94. PubMed ID: 1692060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunostimulating properties of synthetic derivatives of muramyl dipeptide and glucosaminyl muramyl dipeptide in vitro].
    Rakhmilevich AL; Migdal TL; Rakhimova MS; Shneĭderova MA; Chirva VIa; Zemliakov AE
    Antibiot Khimioter; 1989 Nov; 34(11):836-9. PubMed ID: 2633699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of immunomodulatory properties of muramyl peptides on immune system cells of young and old mice.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):149-63. PubMed ID: 8077604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
    Fuks BB; Rakhmilevich AL; Pimenov AA; Dubrovskaia AG
    Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipophilic muramyl dipeptide-induced changes in electron microscopic morphology and phagocytic function of murine macrophages.
    Masihi KN; Ozel M; Lange W; Azuma I
    J Biol Response Mod; 1986 Feb; 5(1):20-6. PubMed ID: 3958752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [N-acetylmuramyl-L-alanyl-D-isoglutamine glycosides. Effect of glycoside center configuration and aglycone nature on biological activity].
    Zemliakov AE; Tsikalov VV; Kaliuzhin OV; Kur'ianov VO; Chirva VIa
    Bioorg Khim; 2003; 29(3):316-22. PubMed ID: 12845808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effects of MDP-Lys(L18) on mouse megakaryocyte progenitor cells (CFU-Meg).
    Komiya I; Kuriya S; Akahane K; Nomura T
    Exp Hematol; 1992 May; 20(4):517-22. PubMed ID: 1568468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of macrophage cytotoxic factors induced by new desmuramyl acylpseudopeptide analogs of muramyl dipeptide.
    Breton P; Petit C; Bousser MT; Monsigny M; Mayer R; Roche AC
    Oncol Res; 1992; 4(3):103-7. PubMed ID: 1617210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.